#cognitive decline

1 article

A wide, minimalist editorial still life on a soft, warm-gray linen surface lit by gentle diffused morning window light. At center sit two identical small amber glass supplement bottles, one slightly in front of the other, with plain matte cream labels and no readable text. In front of them, two matching shallow ceramic dishes in muted sage green hold identical small ivory capsules. The capsules are nearly indistinguishable, which quietly suggests placebo versus active. Beside the dishes, a few wheat germ grains, a small cluster of aged cheddar-toned cheese shards, and a halved ripe mushroom hint at natural spermidine food sources. They are arranged with careful negative space.

On the left, a delicate balance scale in brushed brass sits perfectly level, its two small pans empty and even, as a subtle visual metaphor for "no difference." On the right, a neat open notebook with soft blurred pencil lines and a single sprig of dried eucalyptus lies beside a pair of thin round tortoiseshell reading glasses, suggesting older adults and memory without showing any people.

The background is a softly blurred pale oat-colored wall with a long gentle shadow cast diagonally across the scene from a window. The color palette is muted and modern: warm cream, sage green, amber, soft brass, and dusty terracotta accents. Shallow depth of field keeps the bottles and scale crisp while the edges melt into a creamy blur. The mood is calm, thoughtful, and quietly skeptical, like a trendy health and science journal feature. Fine film grain, a subtle matte finish, and a balanced asymmetrical composition leave open space in the upper right for headline overlay. Photographed from a slightly elevated three-quarter angle, high-end editorial photography style.

¿Spermidina para la memoria? Un ensayo de 12 meses en 100 adultos mayores no mostró ventaja sobre placebo

BY DR. SYNAPSE · 15 oct 2026

La spermidina ha sido promocionada como un suplemento protector del cerebro, basándose en investigaciones sobre autofagia y en estudios con animales. El ensayo SmartAge la evaluó en 100 adultos mayores con deterioro cognitivo subjetivo, administrándoles aproximadamente 0,9 mg diarios durante 12 meses. El endpoint primario de memoria no superó al placebo (diferencia = ‑0,03; p = 0,47) y los secundarios también fueron negativos. Los indicios exploratorios sobre inflamación y memoria verbal no se confirmaron. A continuación, se detallan las implicaciones de este hallazgo para quienes consideren tomar spermidina y se describen las limitaciones del estudio.

#cognitive decline

¿Spermidina para la memoria? Un ensayo de 12 meses en 100 adultos mayores no mostró ventaja sobre placebo

¿Spermidina para la memoria? Un ensayo de 12 meses en 100 adultos mayores no mostró ventaja sobre placebo